TRINITY BIOTECH PLC's ticker is TRIB and the CUSIP is 896438306. A total of 78 filers reported holding TRINITY BIOTECH PLC in Q1 2016. The put-call ratio across all filers is 5.33 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $491,000 | +15.5% | 37,163 | -0.7% | 0.01% | +12.5% |
| Q2 2016 | $425,000 | -39.5% | 37,443 | -37.8% | 0.01% | -42.9% |
| Q1 2016 | $702,000 | -0.7% | 60,220 | +0.2% | 0.01% | 0.0% |
| Q4 2015 | $707,000 | -67.6% | 60,080 | -68.5% | 0.01% | -68.2% |
| Q3 2015 | $2,183,000 | -32.9% | 190,822 | +5.9% | 0.04% | -24.1% |
| Q2 2015 | $3,253,000 | +9.1% | 180,117 | +16.3% | 0.06% | +7.4% |
| Q1 2015 | $2,981,000 | -1.3% | 154,882 | -10.2% | 0.05% | -3.6% |
| Q4 2014 | $3,020,000 | -7.4% | 172,499 | -3.3% | 0.06% | -8.2% |
| Q3 2014 | $3,260,000 | -21.3% | 178,431 | -0.8% | 0.06% | -18.7% |
| Q2 2014 | $4,142,000 | -4.0% | 179,860 | +1.0% | 0.08% | -5.1% |
| Q1 2014 | $4,314,000 | +22.2% | 178,037 | +26.8% | 0.08% | +21.5% |
| Q4 2013 | $3,530,000 | +31.9% | 140,410 | +14.2% | 0.06% | +16.1% |
| Q3 2013 | $2,676,000 | +54.0% | 122,977 | +19.2% | 0.06% | +40.0% |
| Q2 2013 | $1,738,000 | – | 103,133 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACK Asset Management | 928,000 | $10,616,000 | 4.44% |
| GOLDMAN CAPITAL MANAGEMENT INC | 350,961 | $4,015,000 | 2.86% |
| Paradice Investment Management LLC | 992,235 | $11,351,000 | 2.07% |
| Centaur Capital | 77,500 | $887,000 | 1.33% |
| Adirondack Funds | 302,305 | $3,458,000 | 1.33% |
| Adirondack Research & Management Inc. | 302,305 | $3,458,000 | 1.33% |
| RK Capital | 565,472 | $6,469,000 | 1.18% |
| Lyon Street Capital, LLC | 140,943 | $1,612,000 | 1.17% |
| Benchmark Capital Advisors | 89,941 | $1,029,000 | 0.84% |
| KEANE CAPITAL MANAGEMENT INC | 55,045 | $630,000 | 0.83% |